"
One serious but non-fatal adverse event was reported during the trial with 60 participants, according to the data presented at the conference. There were no reports of severe side-effects for patients taking amycretin, while there were a total of 242 reports of mild and moderate side effects."
So, what was this serious but non-fatal adverse effect?